Novo Nordisk A/S
NOVO-B
Rang in Aktien
#107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Aktienkurs
$39.74
Marktkapitalisierung
$175.38B
Veränderung (1 Tag)
1.28%
Veränderung (1 Jahr)
-25.58%
Land
DK
Handel Novo Nordisk A/S (NOVO-B)
Kategorie
Healthcare
Kursverlauf für Novo Nordisk A/S (NOVO-B)
Höchster Schlusskurs: $40.26 am 2026-10-01
Niedrigster Schlusskurs: $0.14 am 1988-03-01
Niedrigster Schlusskurs: $0.14 am 1988-03-01
Kursverlauf der Aktie von Novo Nordisk A/S von 1988 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -4.45% |
| 2025 | -53.02% |
| 2024 | 4.21% |
| 2023 | 52.47% |
| 2022 | 18.08% |
| 2021 | 58.61% |
| 2020 | 21.95% |
| 2019 | 25.17% |
| 2018 | -13.06% |
| 2017 | 48.68% |
| 2016 | -37.84% |
| 2015 | 27.24% |
| 2014 | 25.46% |
| 2013 | 10.41% |
| 2012 | 42.79% |
| 2011 | 5.24% |
| 2010 | 62.58% |
| 2009 | 28.20% |
| 2008 | -21.04% |
| 2007 | 59.27% |
| 2006 | 48.38% |
| 2005 | 2.70% |
| 2004 | 38.02% |
| 2003 | 32.64% |
| 2002 | -24.80% |
| 2001 | 5.84% |
| 2000 | 40.15% |
| 1999 | 7.14% |
| 1998 | -13.94% |
| 1997 | 67.94% |
| 1996 | 44.54% |
| 1995 | 33.16% |
| 1994 | -12.19% |
| 1993 | 12.92% |
| 1992 | 8.32% |
| 1991 | 54.12% |
| 1990 | 3.96% |
| 1989 | 25.86% |
| 1988 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $1.31K | 61.21% |
US
|
|
| $268.35 | 39.08% |
US
|
|
| $284.58 | 24.44% |
US
|
|
| $147.45 | 68.30% |
US
|
|
| $482.01 | 30.76% |
CH
|
